1,445
Views
2
CrossRef citations to date
0
Altmetric
research paper

Associations between m-type phospholipase A2 receptor,human leukocyte antigen gene polymorphisms and idiopathic membranous nephropathy

, , , , &
Pages 8833-8844 | Received 10 Aug 2021, Accepted 24 Sep 2021, Published online: 29 Oct 2021

References

  • Dong YF, Sun LW, Zhang B, et al. Clinical features and expression of PLA(2)R in renal tissue with idiopathic membranous nephropathy in children [J]. Zhonghua Er Ke Za Zhi. 2018;56:206–210.
  • Heymann W, Hackel DB, Harwood S, et al. Production of nephrotic syndrome in rats by Freund’s adjuvants and rat kidney suspensions[J]. Pro Soc Exp Biol Med. 1959;100(4):660–664.
  • Takano T, Cybulsky AV, Cupples WA, et al. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis[J]. J Pharmacol Exp Ther. 2003;305(1):240–249.
  • Schmidt H, Williamson D, Ashley‑Koch A. HLA‑DR15 haplotype and multiple sclerosis: a HuGE review. Am J Epidemiol. 2007;165(10):1097–1109.
  • Klouda PT, Manos J, Acheson EJ, et al. Strong association between idiopathic membranous nephropathy and HLA-DRw3 [J]. Lancet. 1979;165(8146):770–771.
  • Vaughan RW, Demaine AG, Welsh KI. A DQA1 allele is strongly associated with idiopathic membranous nephropathy[J]. Tissue Antigens. 1989;34(5):261–269.
  • Kim S, Chin HJ, Na KY, et al. Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy [J]. Nephron Clin Pract. 2011;117(3):c253–c258.
  • Liu YH, Chen CH, Chen SY, et al. Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan [J]. J Biomed Sci. 2010;17(1):81.
  • Thiri M, Honda K, Kashiwase K, et al. High-density association mapping and interaction analysis of PLA2R1 and HLA regions with idiopathic membranous nephropathy in Japanese [J]. Sci Rep. 2016;6(1):38189.
  • Wang F, Wang TT, Liang XW, et al. PLA2R1 and HLA-DQA1 gene variations in idiopathic membranous nephropathy in South China [J]. Ann Acad Med Singap. 2021;50(1):33–41.
  • Stanescu HC, Arcos-Burgos M, Medlar A, et al. Risk HLA-DQA1 and PLA2R1 alleles in idiopathic membranous nephropathy [J]. N Engl J Med. 2011;364(7):616–626.
  • Saeed M, Beggs ML, Walker PD, et al. PLA2R-associated membranous glomerulopathy is modulated by common variants in PLA2R1 and HLA-DQA1 genes [J]. Genes Immun. 2014;15(8):556–561.
  • Kaga H, Komatsudal A, Omokawa A, et al. Analysis of PLA2R1 and HLA-DQA1 sequence variants in Japanese patients with idiopathic and secondary membranous nephropathy [J]. Clin Exp Nephrol. 2018;22(2):275–282.
  • Ramachandran R, Kumar V, Kumar A, et al. PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians [J]. Nephrol Dial Transplan. 2016;31(9):1486–1493.
  • Lv JC, Hou WY, Zhou XJ, et al. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy [J]. J Am Soc Nephrol. 2013;24(8):1323–1329.
  • Coenen M, Hofstra J, Debiec H, et al. Phospholipase A2 Receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy [J]. J Am Soc Nephrol. 2013;24(4):677–683.
  • Bullich G, Ballarín J, Oliver A, et al. HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy[J]. Clin J Am Soc Nephrol. 2014;9(2):335–343.
  • Latt K, Honda K, Thiri M, et al. Identification of a two-SNP PLA2R1 Haplotype and HLA-DRB1 alleles as primary risk associations in idiopathic membranous nephropathy[J]. Sci Rep. 2018 22;8(1):15576.
  • Xu X, Wang G, Chen N, et al. Long-term exposure to air pollution and increased risk of membranous nephropathy in China [J]. J Am Soc Nephro. 2016;27(12):3739–3746.
  • Gupta S, Köttgen A, Hoxha E, et al. Genetics of membranous nephropathy [J]. Nephrol Dial Transplant. 2018;33(9):1493–1502.
  • Salant DJ. Section R.Genetic variants in membranous nephropathy: perhaps a perfect storm rather than a straightforward conformeropathy?[J]. J Am Soc Nephrol. 2013;24(4):677–678.
  • Pan X, Xu J, Ren H, et al. Changing spectrumof biopsy-proven primary glomerular diseases over the past 15 years: a single-center study in China. Contributions to nephrology, 181, 22–30.